Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

PBS. 2020; 10(1): 1-6


Decreased Levels of Fasting Serum Leptin in Patients With Schizophrenia: A Case-Control Study

Cigdem Sahbaz, Omer Faruk Ozer, Ayse Kurtulmus, Ismet Kırpınar, Sinan Guloksuz.




Abstract

Objective: Leptin may be involved in the pathophysiology of metabolic disruptions in schizophrenia. The findings of the leptin level in patients with schizophrenia have been inconclusive. The aim of this study was to evaluate fasting leptin levels in the stable patients with schizophrenia and the relationship between leptin levels and gender, BMI, clinical variables such as psychopathology scores, suicidal behaviour and type of medication.

Methods: Forty-eight patients with schizophrenia and 36 age-gender-BMI matched healthy controls (HC) were assessed. After 12 h of fasting, venous blood samples were collected in the morning and serum leptin concentrations were measured using the enzyme-linked immunosorbent assay.

Results: Fasting leptin levels were significantly decreased in patients with schizophrenia compared with the HC (P=0.021), also after controlling for age, gender, and body mass index (BMI) (P=0.009). In the regression analysis, being female (ß=−0.51, t=-3.458, p

Key words: Leptin, Schizophrenia, Adiposity, BMI, Gender






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.